COMMUNIQUÉS West-GlobeNewswire

Community and union leaders announce legal action, demand Ford declare a moratorium to save the Durham hospital
23/05/2024
TORONTO, May 23, 2024 (GLOBE NEWSWIRE) -- The Durham hospital, located in Grey County, dates back t o 1910 . Its community supported its survival through two World Wars, the Great Depression, amalgamation, and many [...]
Sequana Medical announces results of Annual and Extraordinary General Meetings of Shareholders
23/05/2024
PRESS RELEASE REGULATED INFORMATION 23 May 2024, 06:00 pm CEST Ghent, Belgium – 23 May 2024 – Sequana Medical NV (Euronext Brussels: SEQUA) (the " Company " or " Sequana Medical "), a pioneer in the treatment of fluid [...]
TruBridge Receives HFMA Peer Review Designation
23/05/2024
CHICAGO, May 23, 2024 (GLOBE NEWSWIRE) -- The Healthcare Financial Management Association (HFMA) recently reviewed TruBridge Medical Coding Services, using the Peer Review process. After undergoing rigorous review, [...]
Kno2 and Docusign Revolutionize Provider-to-Provider Signature Workflows in Healthcare
23/05/2024
BOISE, Idaho, May 23, 2024 (GLOBE NEWSWIRE) -- Kno2®, the leader in interoperable healthcare communication is excited to announce the transformation of provider-to-provider signature workflows in the healthcare industry [...]
New York Blood Center Enterprises Celebrates the Expansion of Cell & Gene Therapy GMP Manufacturing Capabilities at the Grand Opening of Louisville, Kentucky Site
23/05/2024
NEW YORK and LOUISVILLE, Ky., May 23, 2024 (GLOBE NEWSWIRE) -- Comprehensive Cell Solutions (CCS), a business unit of New York Blood Center Enterprises (NYBCe), announced today the grand opening of its GMP facility, [...]
Syneos Health Leaders Recognized as PM360 ELITE 100 Award Recipients
23/05/2024
Honored for Notable Biopharmaceutical Industry Impact MORRISVILLE, N.C., May 23, 2024 (GLOBE NEWSWIRE) -- Syneos Health ® , a leading fully integrated biopharmaceutical solutions organization, today announced PM360 has [...]
Syntekabio to Showcase Advanced AI Drug Discovery Technologies at BIO International Convention 2024
23/05/2024
Explore Syntekabio's Cutting-Edge Solutions at Booth 5435 NEW YORK, May 23, 2024 (GLOBE NEWSWIRE) -- Syntekabio (226330.KQ), a global artificial intelligence (AI) drug discovery pioneer, today announced its [...]
Nyxoah Annonce la Fixation du Prix de l'Offre
23/05/2024
INFORMATIONS PRIVILÉGIÉES INFORMATIONS RÉGLEMENTÉES Nyxoah Annonce la Fixation du Prix de l'Offre Mont-Saint-Guibert, Belgique – 23 mai 2024, 15h50 CET / 9h50 ET - Nyxoah SA (Euronext Brussels/ Nasdaq : NYXH) ("Nyxoah" [...]
Nyxoah Announces Pricing of Offering
23/05/2024
REGULATED INFORMATION INSIDE INFORMATION Nyxoah Announces Pricing of Offering Mont-Saint-Guibert, Belgium – May 23, 2024, 3:50 pm CET / 9:50 am ET – Nyxoah SA (Euronext Brussels/Nasdaq: NYXH) (“Nyxoah” or the “Company [...]
Apnimed Announces a Robust Slate of Presentations at SLEEP 2024, Including an Analysis of the Prevalence of Obesity in Obstructive Sleep Apnea
23/05/2024
New Data Underscore the Need for New OSA Treatments That Go Beyond Weight Loss to Address the Neuromuscular Root Cause of the Disease Oral Presentations include Rationale and Design of SynAIRgy Phase 3 Study for AD109, [...]
Autonomix Preclinical Study Successfully Demonstrates That Nerve Ablation Can Slow Tumor Metastasis in Pancreatic Cancer
23/05/2024
Results from the preclinical study demonstrated statistically significant reduction of metastases and statistically significant reduction in tumor mass Lori Bisson, Chief Executive Officer discusses the animal study in [...]
Developed in Collaboration with Leading Scientists, New ResMed-Supported Research at ATS 2024 Provides Evidence of the Effectiveness and Critical Role of Positive Airway Pressure Therapy
23/05/2024
Among 26 ResMed-supported abstracts, these were the highlights: New findings show positive airway pressure (PAP) therapy reduced risks of death and hospitalization for patients with obstructive sleep apnea (OSA) [...]
Helius Medical Technologies to Exhibit at 2024 CMSC Annual Meeting, Marking a Year of Achievements: Making PoNS More Available to People with MS
23/05/2024
Company Will Highlight Major Milestones on Accessibility and Reimbursement Fronts NEWTOWN, Pa., May 23, 2024 (GLOBE NEWSWIRE) -- Helius Medical Technologies, Inc. (NASDAQ: HSDT) (“Helius” or the “Company”), a neurotech [...]
Precision Optics to Participate in the Lytham Partners Spring 2024 Investor Conference on May 30, 2024
23/05/2024
GARDNER, Mass., May 23, 2024 (GLOBE NEWSWIRE) -- Precision Optics Corporation, Inc. (NASDAQ: POCI), a leading designer and manufacturer of advanced optical instruments for the medical and defense industries, today [...]
Coherus Management to Present at the TD Cowen 5th Annual Oncology Innovation Virtual Summit: Insights for ASCO & EHA
23/05/2024
REDWOOD CITY, Calif., May 23, 2024 (GLOBE NEWSWIRE) -- Coherus BioSciences, Inc. (Coherus, Nasdaq: CHRS) today announced that senior management will present at the upcoming TD Cowen 5th Annual Oncology Innovation [...]
Vistin Pharma ASA: Minutes from the annual general meeting 2024
23/05/2024
Oslo, Norway, 23 May 2024 Vistin Pharma ASA (OSE: VISTN), please find attached the minutes from the annual general meeting held today, on the 23 May 2024. All matters were resolved as proposed in the call for the annual [...]
Altamira Therapeutics Announces Dissemination of Positive Results from Bentrio Trial in Seasonal Allergic Rhinitis Through Social Media Channels of Top Allergy Journal
23/05/2024
Hamilton, Bermuda, May 23, 2024 (GLOBE NEWSWIRE) -- HAMIL TON, BERMUDA – May 23, 2024 -- Altamira Therapeutics Ltd. (“Altamira” or the “Company”) (Nasdaq:CYTO), a company dedicated to developing and commercializing RNA [...]
Brain Cancer Canada Awards an $80,000 research grant to the development of dual function therapies that harness the body's own immune system to kill brain tumour cells in glioblastomas
23/05/2024
TORONTO, May 23, 2024 (GLOBE NEWSWIRE) -- Brain Cancer Canada is excited to announce $80,000 research grant has been awarded to Dr. Peter Stirling, PhD, Associate Professor at the University of British Columbia and [...]
Yield10 Bioscience Announces Addition of Camelina to INTERLINE® Herbicide Label
23/05/2024
- EPA approved an amendment to the label of INTERLINE herbicide to include Camelina -The supplemental label now allows application of INTERLINE for over-the-top weed control in Camelina WOBURN, Mass., May 23, 2024 ( [...]

Pages